Suppr超能文献

端粒酶活性仅在宫颈癌及一部分宫颈上皮内瘤变III级病变中存在:与其催化亚基信使核糖核酸水平升高及高危型人乳头瘤病毒DNA密切相关。

Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.

作者信息

Snijders P J, van Duin M, Walboomers J M, Steenbergen R D, Risse E K, Helmerhorst T J, Verheijen R H, Meijer C J

机构信息

Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Cancer Res. 1998 Sep 1;58(17):3812-8.

PMID:9731489
Abstract

In this study, we investigated telomerase activity and human telomerase reverse transcriptase (hTERT) mRNA expression in relation to high-risk human papillomavirus (HPV) DNA presence in the spectrum of cervical premalignant lesions. Reconstruction experiments revealed that telomerase activity determined by the telomeric repeat amplification protocol assay and hTERT mRNA by reverse transcriptase-PCR could be detected in down to 100 and 1 SiHa cervical cancer cells, respectively. Telomeric repeat amplification protocol analysis on cervical tissue specimens revealed that none of the histomorphologically normal cervical samples (n = 8) and cervical intraepithelial neoplasia (CIN) grade I (n = 10) and grade II (n = 8) lesions had detectable telomerase activity. However, telomerase activity was shown in 40% of CIN grade III lesions (n = 15) and 96% of squamous cell carcinomas (n = 24). Despite the fact that hTERT mRNA was found at much higher frequencies, semiquantitative reverse transcriptase-PCR revealed that elevated hTERT mRNA levels were strongly correlated with detectable telomerase activity. Furthermore, telomerase activity and elevated hTERT mRNA levels were only detected in cases that contained high-risk HPV DNA. In contrast, low or undetectable hTERT mRNA levels were demonstrated in both high-risk HPV positive and negative cases. These data indicate that telomerase activity detectable with the assay used and concomitant elevated levels of hTERT mRNA reflect a rather late step in the CIN to squamous cell carcinoma sequence, which follows infection with high-risk HPV.

摘要

在本研究中,我们调查了宫颈上皮内瘤变范围内端粒酶活性及人端粒酶逆转录酶(hTERT)mRNA表达与高危型人乳头瘤病毒(HPV)DNA存在情况的关系。重建实验显示,分别采用端粒重复序列扩增法检测端粒酶活性以及逆转录聚合酶链反应检测hTERT mRNA,在低至100个SiHa宫颈癌细胞和1个SiHa宫颈癌细胞中均可检测到。对宫颈组织标本进行端粒重复序列扩增法分析显示,组织形态学正常的宫颈样本(n = 8)、宫颈上皮内瘤变(CIN)I级(n = 10)和II级(n = 8)病变均未检测到可检测的端粒酶活性。然而,40%的CIN III级病变(n = 15)和96%的鳞状细胞癌(n = 24)显示有端粒酶活性。尽管hTERT mRNA的检出频率更高,但半定量逆转录聚合酶链反应显示,hTERT mRNA水平升高与可检测的端粒酶活性密切相关。此外,仅在含有高危型HPV DNA的病例中检测到端粒酶活性和hTERT mRNA水平升高。相比之下,高危型HPV阳性和阴性病例中均显示hTERT mRNA水平较低或无法检测到。这些数据表明,使用该检测方法可检测到的端粒酶活性以及hTERT mRNA水平的相应升高反映了CIN进展为鳞状细胞癌序列中相当靠后的阶段,该阶段发生在高危型HPV感染之后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验